Katrina Alison Armstrong, M.D.
This page shows the publications co-authored by Katrina Armstrong and Thomas Randall.
Health Care Disparities in Hereditary Ovarian Cancer: Are We Reaching the Underserved Population? Curr Treat Options Oncol. 2016 08; 17(8):39.
Differences in treatment and outcome between African-American and white women with endometrial cancer. J Clin Oncol. 2003 Nov 15; 21(22):4200-6.
Racial differences in surgeons and hospitals for endometrial cancer treatment. Med Care. 2011 Feb; 49(2):207-14.
Does ovarian cancer treatment and survival differ by the specialty providing chemotherapy? J Clin Oncol. 2007 Apr 01; 25(10):1169-75.
Hormone replacement therapy and life expectancy after prophylactic oophorectomy in women with BRCA1/2 mutations: a decision analysis. J Clin Oncol. 2004 Mar 15; 22(6):1045-54.
Cost-effectiveness of raloxifene and hormone replacement therapy in postmenopausal women: impact of breast cancer risk. Obstet Gynecol. 2001 Dec; 98(6):996-1003.
Variation in chemotherapy utilization in ovarian cancer: the relative contribution of geography. Health Serv Res. 2006 Dec; 41(6):2201-18.
Explaining differences in chemotherapy utilization in ovarian cancer between health service areas. J Clin Oncol. 2004 Jul 15; 22(14_suppl):6005.
Ten-year follow-up of ovarian cancer patients after second-look laparotomy with negative findings. Obstet Gynecol. 1999 Jan; 93(1):21-4.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.